Please use this identifier to cite or link to this item:
Title: Haemodynamic effects of ketanserin following coronary artery bypass grafting
Authors: Lee, E.J.E.
Lee, T.L. 
Woo, M. 
Boey, W.K. 
Kumar, A. 
Lee, C.N. 
Issue Date: 1991
Citation: Lee, E.J.E., Lee, T.L., Woo, M., Boey, W.K., Kumar, A., Lee, C.N. (1991). Haemodynamic effects of ketanserin following coronary artery bypass grafting. Anaesthesia and Intensive Care 19 (3) : 351-356. ScholarBank@NUS Repository.
Abstract: The haemodynamic effects of ketanserin were studied consecutively in seventeen patients in the intensive care unit following coronary artery bypass grafting. Hypertensive patients (Group I, systolic blood pressure (SBP) ≥ 150 mmHg following discontinuation of nitroprusside, n = 10) received intravenous ketanserin 10 mg and infusion of 0.1 mg·kg-1·hr-1 with additional boluses as required to maintain SBP ≤ 130 mmHg for one hour. Non-hypertensive patients (Group 2, SBP < 150 mmHg, n = 7) received a 5 mg bolus and the same infusion. Ketanserin significantly decreased arterial blood pressure (P < 0.001) in all patients in Group 1. Heart rate was decreased but not significantly. Cardiac index, systemic and pulmonary vascular resistance and pulmonary shunt fraction were not significantly altered from pre-ketanserin values when blood pressure was controlled with nitroprusside. Normotensive patients in Group 2 did not show any undesitable hypotension or significant haemodynamic changes. Mean nitroprusside dose requirements following ketanserin therapy were significantly reduced by 91.6% in Group 1 and 78.4% in Group 2 (P < 0.05). Ketanserin is effective in treating hypertension following coronary artery bypass grafting with an advantage of lack of reflex tachycardia.
Source Title: Anaesthesia and Intensive Care
ISSN: 0310057X
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Page view(s)

checked on May 22, 2019

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.